pdufa.bio
HomeReadouts › December 2026

December 2026 clinical-trial readouts

Updated ยทnext FDA decision on the calendar
trial-readout estimates for December 2026, each row linked to its primary source. Readout dates are estimated primary-completion windows from ClinicalTrials.gov and shift.
← November 2026January 2027 →
49 readouts
EXEL · Dec 2026 (est.)
Cabozantinib: Metastatic Renal Cell Carcinoma
CNTA · Dec 2026 (est.)
cleminorexton: Narcolepsy Type 1
BEAM · Dec 2026 (est.)
BEAM-302: Lymphoblastic Lymphoma
Awaiting dataupdated 18mo ago
BIIB · Dec 2026 (est.)
Felzartamab: Antibody-mediated Rejection
BMY · Dec 2026 (est.)
Nivolumab: Non Small Cell Lung Cancer
CMPX · Dec 2026 (est.)
CTX-009: Biliary Tract Cancer
Awaiting data
CORT · Dec 2026 (est.)
Relacorilant: Cushing Syndrome
Awaiting data
BCDA · Dec 2026 (est.)
Autologous cell therapy: Heart Failure, Systolic
Awaiting dataupdated 7mo ago
AGEN · Dec 2026 (est.)
Balstilimab: Refractory Metastatic Colorectal Cancer
Awaiting dataupdated 8mo ago
ALMS · Dec 2026 (est.)
Open-Label Envudeucitinib: Plaque Psoriasis
Awaiting data
APGE · Dec 2026 (est.)
APG777: Atopic Dermatitis
Awaiting data
AVIR · Dec 2026 (est.)
Bemnifosbuvir-Ruzasvir: HEPATITIS C VIRUS CHRONIC INFECTION
Awaiting data
MDGL · Dec 2026 (est.)
Resmetirom: NASH
Awaiting data
MRK · Dec 2026 (est.)
Pembrolizumab: Squamous Cell Cancer of Head and Neck
ONC · Dec 2026 (est.)
Zanubrutinib: Waldenstrom Macroglobulinemia
PBYI · Dec 2026 (est.)
neratinib: Breast Cancer
Awaiting data
PFE · Dec 2026 (est.)
Elranatamab: Multiple Myeloma
PHAT · Dec 2026 (est.)
Vonoprazan: Eosinophilic Esophagitis
Awaiting data
RGNX · Dec 2026 (est.)
Ranibizumab: AMD
Awaiting data
RNAC · Dec 2026 (est.)
Decartes-08: Systemic Lupus Erythematosus (SLE)
Awaiting data
MANE · Dec 2026 (est.)
VDPHL01: Androgenetic Alopecia
Awaiting dataupdated 4mo ago
LXEO · Dec 2026 (est.)
LX1001: Arrhythmogenic Cardiomyopathy
Awaiting dataupdated 8mo ago
GOSS · Dec 2026 (est.)
Seralutinib: Pulmonary Arterial Hypertension
Awaiting data
INO · Dec 2026 (est.)
VGX-3100: BRCA1/2 Mutation
IONS · Dec 2026 (est.)
Donidalorsen: Hereditary Angioedema
IXHL · Dec 2026 (est.)
IHL-42X Low Dose: Obstructive Sleep Apnea
Awaiting dataupdated 14mo ago
JAZZ · Dec 2026 (est.)
CPX-351: Acute Myeloid Leukemia (AML) in Remission
KPTI · Dec 2026 (est.)
Rituximab: Relapsed/Refractory Diffuse Large B-cell Lymphoma
Awaiting data
SMMT · Dec 2026 (est.)
Ivonescimab: Stomach Cancer Stage IV
VNDA · Dec 2026 (est.)
VQW-765: Social Anxiety Disorder (SAD)
TRAW · Dec 2026 (est.)
rigosertib: Influenza
Awaiting data
SNDX · Dec 2026 (est.)
Revumenib: Leukemia
XNCR · Dec 2026 (est.)
XMAB20717: Biliary Tract Cancer
Awaiting dataupdated 9mo ago
PFE · Dec 2026 (est.)
Mevrometostat: Metastatic Castration-Resistant Prostate Cancer
CRDF · Dec 2026 (est.)
Onvansertib: Breast Cancer
Awaiting dataupdated 4mo ago
SNY · Dec 2026 (est.)
Rilzabrutinib: Focal Segmental Glomerulosclerosis
SUPN · Dec 2026 (est.)
BIS-001: Focal Impaired Awareness Seizures
Awaiting dataupdated 47mo ago
ARVN · Dec 2026 (est.)
ARV-471: Breast Cancer
Awaiting dataupdated 5mo ago
MNOV · Dec 2026 (est.)
MN-166: Diabetes Mellitus, Type 2
Awaiting dataupdated 5mo ago
PFE · Dec 2026 (est.)
Palbociclib: Breast Cancer
VIR · Dec 2026 (est.)
Tobevibart: Viral Hepatitis
Awaiting data
ACTU · Dec 2026 (est.)
Losartan: Pancreatic Adenocarcinoma
Awaiting data
ADCT · Dec 2026 (est.)
Loncastuximab Tesirine: Chronic Lymphocytic Leukemia
Awaiting dataupdated 9mo ago
ARVN · Dec 2026 (est.)
ARV-471: Breast Cancer
Awaiting data
NVO · Dec 2026 (est.)
Semaglutide: Intestinal Mucositis
JAZZ · Dec 2026 (est.)
Zanidatamab: Breast Cancer
INSM · Dec 2026 (est.)
Treprostinil Palmitil Inhalation Powder: Pulmonary Arterial Hypertension
Awaiting data
EXEL · Dec 2026 (est.)
XL-092: Hepatocellular Carcinoma
INO · Dec 2026 (est.)
VGX-3100: Glioblastoma
Looking for an approval probability for these? We deliberately don't publish one. Here's why, and what we show instead (verified history + base rates).